Compounds > sn 38
Page last updated: 2024-08-26

sn 38 and mitoxantrone

sn 38 has been researched along with mitoxantrone in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (80.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Akiyama, S; Baba, M; Furukawa, T; Nitanda, T; Okamoto, M; Sugimoto, Y; Wang, X1
Imai, Y; Sugimoto, Y; Tsukahara, S; Tsuruo, T; Ueda, K1
Asada, S; Imai, Y; Ishikawa, E; Sugimoto, Y; Tsukahara, S; Tsuruo, T1
Asada, S; Imai, Y; Ishikawa, E; Miwa, M; Sugimoto, Y; Tsukahara, S1
Aichele, D; Bollacke, A; Bouaziz, Z; Cadena, SM; Daflon-Yunes, N; Di Pietro, A; Guillon, J; Jabor Gozzi, G; Jose, J; Lacoudre, A; Le Borgne, M; Marminon, C; Nacereddine, A; Pinaud, N; Valdameri, G; Winter, E; Zeinyeh, W1

Other Studies

5 other study(ies) available for sn 38 and mitoxantrone

ArticleYear
Breast cancer resistance protein (BCRP/ABCG2) induces cellular resistance to HIV-1 nucleoside reverse transcriptase inhibitors.
    Molecular pharmacology, 2003, Volume: 63, Issue:1

    Topics: Anti-HIV Agents; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; CD4-Positive T-Lymphocytes; Cells, Cultured; Doxorubicin; Drug Resistance, Neoplasm; Drug Resistance, Viral; HIV Reverse Transcriptase; HIV-1; Humans; Indoles; Lamivudine; Microbial Sensitivity Tests; Neoplasm Proteins; Reverse Transcriptase Inhibitors; Zidovudine

2003
Reversal of breast cancer resistance protein-mediated drug resistance by estrogen antagonists and agonists.
    Molecular cancer therapeutics, 2003, Volume: 2, Issue:1

    Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Breast Neoplasms; Cell Survival; Diethylstilbestrol; Drug Resistance, Neoplasm; Estrogen Antagonists; Estrogens; Estrone; Female; Humans; K562 Cells; Kinetics; Mitoxantrone; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Tamoxifen; Topotecan; Tumor Cells, Cultured

2003
Breast cancer resistance protein exports sulfated estrogens but not free estrogens.
    Molecular pharmacology, 2003, Volume: 64, Issue:3

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Breast Neoplasms; Cell Line; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Estrogens; Estrogens, Conjugated (USP); Estrone; LLC-PK1 Cells; Models, Molecular; Neoplasm Proteins; Sulfates; Swine

2003
Single amino acid substitutions in the transmembrane domains of breast cancer resistance protein (BCRP) alter cross resistance patterns in transfectants.
    International journal of cancer, 2003, Dec-10, Volume: 107, Issue:5

    Topics: Amino Acid Substitution; Animals; Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Camptothecin; Cell Line; Cell Membrane; DNA, Complementary; Drug Resistance, Multiple; Fibroblasts; Humans; Irinotecan; Kinetics; Mice; Mitoxantrone; Neoplasm Proteins; Recombinant Proteins; Transfection

2003
Converting potent indeno[1,2-b]indole inhibitors of protein kinase CK2 into selective inhibitors of the breast cancer resistance protein ABCG2.
    Journal of medicinal chemistry, 2015, Jan-08, Volume: 58, Issue:1

    Topics: ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Breast Neoplasms; Casein Kinase II; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Female; HEK293 Cells; Humans; Indoles; MCF-7 Cells; Mitoxantrone; Models, Chemical; Molecular Structure; Neoplasm Proteins; Protein Kinase Inhibitors

2015